Skip to content

碧迪医疗(Becton Dickinson)

US · BDX #450 按市值排名 上市于 1970
191.75 -2.01 -1.04%
实时 - 追踪5344个代码 - 心跳于495秒前 · 2026-10-16 19:30

最新新闻

  • Barclays Initiates Becton Dickinson & Co(BDX.US) With Sell Rating, Announces Target Price $165
    \u5e02\u573a\u8d44\u8baf · 2026/10/8
  • 评级变动
    Citi Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Raises Target Price to $208
    \u5e02\u573a\u8d44\u8baf · 2026/8/14
  • RBC Capital Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Maintains Target Price $190
    \u5e02\u573a\u8d44\u8baf · 2026/10/3
  • Barclays Downgrades Becton Dickinson & Co(BDX.US) to Sell Rating, Cuts Target Price to $165
    \u5e02\u573a\u8d44\u8baf · 2026/10/7
  • 评级变动
    Jefferies Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Maintains Target Price $210
    \u5e02\u573a\u8d44\u8baf · 2026/9/8
  • 公司公告
    Nippon Electric Glass: Developed a new product, "BDX-3," of the ultra-thin cover glass for space applications, Starveil.
    JPX · 2026/10/6
  • 公司公告
    GSH cb5.2%241012#: General Announcement-NOTICE OF REDEMPTION AND END OF CONVERSION PERIOD OF CONVERTIBLE BONDS
    SGX · 2024/6/25
  • 评级变动
    BofA Securities Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Raises Target Price to $185
    \u5e02\u573a\u8d44\u8baf · 2026/8/11
  • 公司公告
    GSH cb5.2%241012#: Final Maturity-Mandatory
    SGX · 2024/9/26
  • BofA Securities Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Maintains Target Price $200
    \u5e02\u573a\u8d44\u8baf · 2026/10/7
  • 评级变动
    TD Cowen Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Maintains Target Price $182
    \u5e02\u573a\u8d44\u8baf · 2026/8/8
  • 评级变动
    BofA Securities Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Raises Target Price to $200
    \u5e02\u573a\u8d44\u8baf · 2026/8/31
  • 评级变动
    UBS Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Raises Target Price to $205
    \u5e02\u573a\u8d44\u8baf · 2026/8/12
  • 评级变动
    J.P. Morgan Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Cuts Target Price to $188
    \u5e02\u573a\u8d44\u8baf · 2026/8/11
  • 评级变动
    Stifel Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Maintains Target Price $195
    \u5e02\u573a\u8d44\u8baf · 2026/8/13
  • Citi Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Maintains Target Price $208
    \u5e02\u573a\u8d44\u8baf · 2026/10/5
  • 评级变动
    RBC Capital Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Raises Target Price to $190
    \u5e02\u573a\u8d44\u8baf · 2026/8/13
  • 公司公告
    GSH cb5.2%241012#: Coupon Payment-Mandatory
    SGX · 2024/9/20
  • 公司公告
    GSH cb5.2%241012#: General Announcement-Conversion and Cancellation of Convertible Bonds
    SGX · 2024/8/28
  • 评级变动
    J.P. Morgan Remains a Hold on Becton Dickinson (BDX)
    TipRanks · 2026/8/11
  • 评级变动
    RBC Capital Initiates Becton Dickinson & Co(BDX.US) With Hold Rating, Announces Target Price $180
    \u5e02\u573a\u8d44\u8baf · 2026/8/7
  • GSH Raises S$7.05 Million via SDAX Digital Securities Issuances
    TipRanks · 2026/9/24
  • GSH Corp. Raises SG$18 Million Via Digital Securities
    MT Newswires · 2026/9/25
  • Citi Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Maintains Target Price $208
    \u5e02\u573a\u8d44\u8baf · 2026/8/14
  • 公司公告
    GSH cb5.2%241012#: Notice of 3 Consecutive Years' Losses-Notice of 3 Consecutive Years' Losses
    SGX · 2024/4/9

新闻标题为自动聚合内容,未经我们团队独立核实或编辑。

报价时间 2026-10-16 19:30:05 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

碧迪医疗(Becton Dickinson) 讨论区 0 条评论

发表评论